\u827e\u4f2f\u7dadAbbVie\uff08NYSE:ABBV\uff09<\/a>\u3002<\/p>\n\u827e\u4f2f\u7dad\u8fd1\u671f\u7684\u8ca1\u52d9\u6578\u64da\u53ef\u80fd\u6709\u4e00\u9ede\u8aa4\u5c0e\u6027<\/h2>\n
\u8ddf\u82f1\u5049\u9054\u76f8\u6bd4\uff0c\u827e\u4f2f\u7dad\u4e0d\u50c5\u71b1\u5ea6\u4e0d\u884c\uff0c\u80a1\u50f9\u6700\u8fd1\u751a\u81f3\u9084\u662f\u4e0b\u8dcc\u7684\uff0c\u539f\u56e0\u662f\u8a72\u516c\u53f8\u7684\u589e\u901f\u4e0d\u7406\u60f3\u3002\u4eca\u5e74\u524d3\u500b\u6708\uff0c\u8a72\u516c\u53f8\u6536\u5165\u7e3d\u8a08123\u5104\u7f8e\u5143\uff0c\u540c\u6bd4\u589e\u5e45\u9084\u4e0d\u52301%\u3002<\/p>\n
\u4f46\u9019\u500b\u6578\u64da\u53ef\u80fd\u6703\u6709\u4e00\u9ede\u8aa4\u5c0e\u6027\u3002\u827e\u4f2f\u7dad\u7684\u6536\u5165\u589e\u901f\u4e4b\u6240\u4ee5\u4e0d\u592a\u597d\u770b\uff0c\u5f88\u91cd\u8981\u7684\u539f\u56e0\u662f\u8a72\u516c\u53f8\u7684\u66a2\u92b7\u85e5\uff0c\u985e\u98a8\u6fd5\u6027\u95dc\u7bc0\u708e\u85e5\u7269Humira\u7684\u5c08\u5229\u6b0a\u4fdd\u8b77\u55aa\u5931\uff0c\u92b7\u552e\u984d\u4e0b\u964d\u8fd136%\u81f3\u4e0d\u523023\u5104\u7f8e\u5143\u3002\u6240\u5e78\u7684\u662f\uff0cSkyrizi\u548cRinvoq\u9019\u5169\u6b3e\u514d\u75ab\u85e5\u7269\u6709\u80fd\u529b\u5f4c\u88dc\u9019\u4e00\u6536\u5165\u7f3a\u53e3\uff0c\u904e\u53bb\u4e00\u5b63\u5ea6\u7684\u5408\u8a08\u6536\u5165\u9054\u5230\u4e8631\u5104\u7f8e\u5143\uff0c\u540c\u6bd4\u589e\u901f\u5206\u5225\u9ad8\u905448%\u548c59%\u3002<\/p>\n
\u827e\u4f2f\u7dad\u7684\u589e\u9577\u6f5b\u529b\u53ef\u671f<\/h2>\n
\u827e\u4f2f\u7dad\u9084\u4e00\u76f4\u6295\u8cc7\u672a\u4f86\u7684\u589e\u9577\u6a5f\u6703\uff0c\u6bd4\u5982\u8aaa\u4eca\u5e74\u65e9\u4e9b\u6642\u5019\u5b8c\u6210\u4e86\u5c0d\u6297\u9ad4\u5076\u806f\u85e5\u7269\uff08ADC\uff09\u751f\u7522\u5546ImmunoGen 100\u5104\u7f8e\u5143\u7684\u6536\u8cfc\uff0c\u540c\u6642\u8a08\u528387\u5104\u7f8e\u5143\u6536\u8cfcCerevel Therapeutics\uff0c\u5f37\u5316\u516c\u53f8\u7684\u795e\u7d93\u7cfb\u7d71\u79d1\u5b78\u7814\u767c\u7ba1\u7dda\u548c\u696d\u52d9\u3002\u827e\u4f2f\u7dad\u7684\u9996\u5e2d\u57f7\u884c\u5b98Richard A. Gonzalez\u76f8\u4fe1\uff0c\u516c\u53f8\u7684\u6295\u8cc7\u4e0d\u4e45\u5c31\u5c07\u8fce\u4f86\u6536\u7a6b\uff0c\u4ed6\u9810\u8a08\u516c\u53f82025\u5e74\u5c07\u6062\u5fa9\u5f37\u52c1\u589e\u9577\uff0c2030\u5e74\u4e4b\u524d\u7684\u5e74\u8907\u5408\u589e\u9577\u7387\uff08CAGR\uff09\u53ef\u4ee5\u9054\u5230\u9ad8\u7b49\u500b\u4f4d\u6578\u3002<\/p>\n
\u5c0d\u65bc\u6210\u9577\u578b\u6295\u8cc7\u8005\u4f86\u8aaa\uff0c\u9019\u4e00\u589e\u901f\u6c34\u5e73\u53ef\u80fd\u4f9d\u7136\u6709\u9ede\u4f4e\uff0c\u4f46\u597d\u5728\u827e\u4f2f\u7dad\u64c1\u6709\u5927\u91cf\u7684\u81ea\u7531\u73fe\u91d1\uff0c\u904e\u53bb3\u5e74\u5275\u9020\u4e86\u8d85\u904e680\u5104\u7f8e\u5143\u7684\u81ea\u7531\u73fe\u91d1\u6d41\uff0c\u5f9e\u800c\u652f\u6301\u516c\u53f8\u672a\u4f86\u7684\u6536\u8cfc\u53ca\u5176\u4ed6\u6a5f\u6703\u3002<\/p>\n
\u4f30\u503c\u548c\u80a1\u606f<\/h2>\n
\u4eca\u5e74\u8fc4\u4eca\uff0c\u827e\u4f2f\u7dad\u80a1\u50f9\u50c5\u4e0a\u6f325%\uff0c\u4f46\u52d5\u614b\u5e02\u76c8\u7387\u4e5f\u53ea\u670915\uff0cPEG\uff08\u5e02\u76c8\u7387\u76f8\u5c0d\u76c8\u5229\u589e\u9577\u6bd4\u7387\uff09\u6bd4\u7387\u66f4\u662f\u4f4e\u81f30.4\u3002\u76f8\u6bd4\u4e4b\u4e0b\uff0c\u82f1\u5049\u9054\u7684PEG\u6bd4\u7387\u57281.3\u9644\u8fd1\u3002\u9664\u4e86\u4f4e\u4f30\u503c\uff0c\u8a72\u80a1\u76ee\u524d\u80a1\u606f\u7387\u90543.8%\uff0c\u662f\u6a19\u666e500\u6307\u6578\u5e73\u5747\u6c34\u5e731.4%\u7684\u5169\u500d\u591a\u3002<\/p>\n
\u827e\u4f2f\u7dad\u503c\u5f97\u8cb7\u5165\u4e26\u6301\u6709<\/h2>\n
\u96d6\u7136\u8fd1\u671f\u7684\u696d\u7e3e\u4e0d\u592a\u51fa\u8272\uff0c\u4f46\u6211\u5011\u4f9d\u7136\u6709\u7406\u7531\u9577\u671f\u770b\u597d\u827e\u4f2f\u7dad\u3002\u6295\u8cc7\u8005\u53ef\u4ee5\u4e00\u908a\u6536\u53d6\u80a1\u606f\u6536\u5165\uff0c\u4e00\u908a\u7b49\u5f85\u516c\u53f8\u696d\u7e3e\u7684\u5411\u597d\uff0c\u5f9e\u800c\u5e36\u52d5\u80a1\u50f9\u7684\u4e0a\u6f32\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u82f1\u5049\u9054NVIDIA\uff08NASDAQ:NVDA\uff09\u662f\u4e00\u96bb\u512a\u8cea\u7684\u6210\u9577\u80a1\uff0c\u5c24\u5176\u662f\u5c0d\u9577\u671f\u6295\u8cc7\u8005\u4f86\u8aaa\u3002\u4f46\u7f8e\u4e2d\u4e0d\u8db3\u7684\u662f\uff0c\u8a72\u80a1\u52d5 […]<\/p>\n","protected":false},"author":27,"featured_media":475563,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[2156,927,1860,564],"class_list":["post-498173","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-2156","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","sectors-technology-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/498173","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=498173"}],"version-history":[{"count":3,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/498173\/revisions"}],"predecessor-version":[{"id":498176,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/498173\/revisions\/498176"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/475563"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=498173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=498173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=498173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}